Wells Fargo & Company Third Harmonic Bio, Inc. Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	$3.36 - $5.48 $9,952 - $16,231	2,962 Added 22.51%	16,118 $87,000
Q1 2025 May 13, 2025	BUY	$3.25 - $11.17 $4,936 - $16,967	1,519 Added 13.05%	13,156 $45,000
Q4 2024 Feb 12, 2025	BUY	$10.29 - $15.4 $26,085 - $39,039	2,535 Added 27.85%	11,637 $119,000
Q3 2024 Nov 13, 2024	BUY	$10.86 - $15.0 $4,246 - $5,865	391 Added 4.49%	9,102 $123,000
Q2 2024 Aug 13, 2024	BUY	$8.74 - $15.54 $16,169 - $28,749	1,850 Added 26.96%	8,711 $113,000

Q1 2024 May 10, 2024	BUY	$8.6 - $11.24 $7,611 - $9,947	885 Added 14.81%	6,861 $64,000
Q4 2023 Feb 09, 2024	BUY	$5.97 - $11.47 $7,062 - $13,569	1,183 Added 24.68%	5,976 $65,000
Q3 2023 Nov 13, 2023	SELL	$4.92 - $7.09 $12,644 - $18,221	-2,570 Reduced 34.9%	4,793 $30,000
Q2 2023 Aug 15, 2023	BUY	$4.18 - $5.33 $21,075 - $26,873	5,042 Added 217.23%	7,363 $35,000
Q1 2023 May 12, 2023	BUY	$3.95 - $4.49 $9,167 - $10,421	2,321 New	2,321 $9,000

Others Institutions Holding THRD

# of Institutions

21

Shares Held

5.8M

Call Options Held

0

Put Options Held

0

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $217M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.